Posters
« Back
Proteomics a Major New Technology for Drug Discovery
EP34268
Poster Title: Proteomics a Major New Technology for Drug Discovery
Submitted on 28 Oct 2020
Author(s): Creative Proteomics
Affiliations: Creative Proteomics
Poster Views: 168
View poster »


Poster Information
Abstract: Proteomics is a discipline that analyzes the dynamics of protein components, including expression levels and modification states from a holistic perspective, understands the interactions and connections between proteins, reveals the function of proteins and the laws of cell life, and studies all proteins in cells and their behaviors. The concept of proteomics has been used in the field of pharmaceutical research, thereby developing pharmacoproteomics. This field includes discovery of all possible drug targets and all possible compounds for these targets; study of drug action mechanisms and toxicology; drug screening. It is also possible to classify patients according to protein profiles, to provide individualized treatment, and to predict drug efficacy. Nowadays, pharmaceutical proteomics has penetrated into all aspects of drug discovery and clinical application.Summary: Proteomics is a discipline that analyzes the dynamics of protein components, including expression levels and modification states from a holistic perspective, understands the interactions and connections between proteins, reveals the function of proteins and the laws of cell life, and studies all proteins in cells and their behaviors. References: https://www.creative-proteomics.com/pdf/proteomics-a-major-new-technology-for-drug-discovery.pdfReport abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Creative Proteomics: Bioinformatics Analysis Network Analysis
Creative Proteomics

Creative Proteomics: Protein post-translational modification analysis
Creative Proteomics

Creative Proteomics: Flow Cytometry vs Microscopy
Creative Proteomics

CCS-centric protein identification using IM Score
Robin Park1, Patrick Garrett3, Sven Brehmer2, Titus Jung3, Vijayaraja Gnanasambandan1, Marc-Antoine Beauvais1, Sebastian Wehner2, Lennard Pfennig2, Hyunsoo Kim3, Christopher Adams1, Dennis Trede2, John R. Yates, III3, Rohan Thakur1 1Bruker Daltonics Inc., USA 2Bruker Daltonik GmbH, Bremen, Germany 3Scripps Research, San Diego, USA

Real-time search of Ubiquitin diGLY modified peptides and PaSER acquisition control on the timsTOF PRO
Christopher Adams1; Robin Park1; Nagarjuna Nagaraj4; Sven Brehmer4; Matt Willetts3; Elizabeth Gordon3; Barry M. Zee2; Hayley Peckham2; Kimberly Lee2; Tharan Srikumar3 1Bruker,San Jose,CA;2Cell Signaling Technologies, Danvers, MA;3Bruker, Billerica, MA; 4Bruker, Bremen, Germany